Level Bio AB (publ) (NGM:LEVBIO)

Level Bio AB Income Statement

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Revenue	32.36	25.1	26.1	34.33	43.96
Other Revenue	-0	-	-	-	-
Revenue	32.36	25.1	26.1	34.33	43.96
Revenue Growth (YoY)	28.94%	-3.83%	-23.99%	-21.91%	86.86%
Cost of Revenue	15.31	11.6	13.79	19.08	26.08
Gross Profit	17.06	13.49	12.31	15.25	17.88
Selling, General & Admin	18.24	19.6	20.33	15.87	12.05
Other Operating Expenses	0.11	-0.21	-0.48	-0.46	-0.69
Operating Expenses	20.54	21.58	22.04	17.59	12.62
Operating Income	-3.49	-8.08	-9.73	-2.33	5.26
Interest Expense	-0.08	-0.13	-0.01	-0.08	-0.04
Interest & Investment Income	-	0.02	0.05	0	-
Other Non Operating Income (Expenses)	0	-	-	-	-
EBT Excluding Unusual Items	-3.57	-8.19	-9.69	-2.41	5.21
Pretax Income	-3.57	-8.19	-9.69	-2.41	5.21
Income Tax Expense	-0.03	-0.32	-0.22	-0.19	0.06
Net Income	-3.54	-7.87	-9.48	-2.22	5.16
Net Income to Common	-3.54	-7.87	-9.48	-2.22	5.16
Net Income Growth	-	-	-	-	240.69%
Shares Outstanding (Basic)	68	63	63	63	59
Shares Outstanding (Diluted)	68	65	63	63	63
Shares Change (YoY)	4.79%	2.96%	-	-	20.00%
EPS (Basic)	-0.05	-0.12	-0.15	-0.04	0.09
EPS (Diluted)	-0.05	-0.12	-0.15	-0.04	0.08
EPS Growth	-	-	-	-	179.27%
Free Cash Flow	0.82	-4.46	-5.49	2.79	1.63
Free Cash Flow Per Share	0.01	-0.07	-0.09	0.04	0.03
Gross Margin	52.70%	53.77%	47.16%	44.43%	40.67%
Operating Margin	-10.78%	-32.21%	-37.30%	-6.79%	11.96%
Profit Margin	-10.94%	-31.37%	-36.31%	-6.48%	11.73%
Free Cash Flow Margin	2.53%	-17.78%	-21.03%	8.14%	3.70%
EBITDA	-1.3	-6.94	-8.58	-1.19	5.91
EBITDA Margin	-4.01%	-27.65%	-32.87%	-3.48%	13.45%
D&A For EBITDA	2.19	1.14	1.15	1.14	0.65
EBIT	-3.49	-8.08	-9.73	-2.33	5.26
EBIT Margin	-10.78%	-32.21%	-37.30%	-6.79%	11.96%
Effective Tax Rate	-	-	-	-	1.09%
Revenue as Reported	32.49	25.18	26.67	34.68	44.65

Source: S&P Global Market Intelligence. Standard template. Financial Sources.